Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 55,288,081 | 50,072,983 | 51,162,924 | 64,021,069 | 59,636,648 | 280,181,705 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 386,677,912 | 385,698,701 | 388,404,186 | 434,102,011 | 508,370,767 | 2,103,253,577 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 441,965,993 | 435,771,684 | 439,567,110 | 498,123,080 | 568,007,415 | 2,383,435,282 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | 0 | 0 | 0 | 0 | 0 |
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | 0 | 53,540,708 | 63,611,960 | 76,145,656 | 193,298,324 |
| c | Add lines 7a and 7b.. | 0 | 0 | 53,540,708 | 63,611,960 | 76,145,656 | 193,298,324 |
| 8 | Public support. (Subtract line 7c from line 6.) | 2,190,136,958 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 441,965,993 | 435,771,684 | 439,567,110 | 498,123,080 | 568,007,415 | 2,383,435,282 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 3,257,641 | 3,232,070 | 2,680,739 | 2,976,195 | 3,004,500 | 15,151,145 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | 3,257,641 | 3,232,070 | 2,680,739 | 2,976,195 | 3,004,500 | 15,151,145 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 65,221 | 85,122 | 83,992 | 82,787 | 113,302 | 430,424 |
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 0 | 0 | 0 | 1,800 | 3,000 | 4,800 |
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 445,288,855 | 439,088,876 | 442,331,841 | 501,183,862 | 571,128,217 | 2,399,021,651 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| Schedule A, Part III, Line 12 Other Income | DESCRIPTION - MISCELLANEOUS, COLUMN A - , COLUMN B - , COLUMN C - , COLUMN D - 1800.0, COLUMN E - 3000.0, COLUMN F - 4800.0; |
| Software ID: | 22016089 |
| Software Version: | 2022v5.0 |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 1 | AT NMDP, WE BELIEVE EACH OF US HOLDS THE KEY TO CURING BLOOD CANCERS AND DISORDERS. AS A GLOBAL NONPROFIT LEADER IN CELL THERAPY, NMDP CREATES ESSENTIAL CONNECTIONS BETWEEN RESEARCHERS AND SUPPORTERS TO INSPIRE ACTION AND ACCELERATE INNOVATION TO FIND LIFE-SAVING CURES. WITH THE HELP OF BLOOD STEM DONORS FROM THE WORLD'S MOST DIVERSE REGISTRY AND OUR EXTENSIVE NETWORK OF TRANSPLANT PARTERS, PHYSICIANS AND CAREGIVERS, WE'RE EXPANDING ACCESS TO TREATMENT SO THAT EVERY PATIENT CAN RECEIVE THEIR LIFE-SAVING CELL THERAPY. NMDP. FIND CURES. SAVE LIVES. . OUR MISSION: WE SAVE LIVES THROUGH CELL THERAPY. OUR VISION: CREATE A WORLD WHERE EVERY PATIENT CAN RECEIVE THEIR LIFE-SAVING CELL THERAPY. THE NMDP FOUNDATION RAISES FUNDS FOR THREE PROGRAMS CRITICAL TO OUR LIFE-SAVING MISSION: TRANSPLANT RESEARCH, PATIENT FINANCIAL ASSISTANCE AND DONOR RECRUITMENT. SOME OF THE LIFE-CHANGING WORK THAT WE'RE DOING IS SOLEY FUNDING BY OUR COMMUNITY OF SUPPORTERS. WE CONDUCT RESEARCH THROUGH OUR RESEARCH PROGRAM, CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH) IN COLLABORATION WITH THE MEDICAL COLLEGE OF WISCONSIN. OUR RESEARCH LEADS TO MORE LIVES SAVED AND AN ENRICHED QUALITY OF LIFE FOR THOUSANDS OF PATIENTS. THROUGH THE NMDP AMY STRELZER MANASEVIT RESEARCH PROGRAM AND OTHER RESEARCH GRANTS, OUTSTANDING EARLY-CAREER RESEARCHERS ARE DOING INNOVATIVE WORK TO FIND SOLUTIONS TO THE COMPLICATIONS THAT CAN ARISE AFTER TRANSPLANT. THEY'RE DEVELOPING TREATMENT APPROACHES THAT WILL HELP THE NEXT GENERATION OF TRANSPLANT PATIENTS LIVE LONGER, HEALTHIER LIVES. PATIENT FINANCIAL ASSISTANCE HELPS COVER TRANSPLANT-RELATED COSTS NOT COVERED BY INSURANCE THAT CAUSE SIGNIFICANT HARDSHIP OR EVEN PREVENT PATIENTS FROM MOVING FORWARD WITH TRANSPLANT. COSTS LIKE TRANSPORTATION, LODGING, LOST WAGES AND PRESCRIPTIONS. NMDP CONNECTS PATIENTS WITH A MATCHING, UNRELATED DONOR, A SELFLESS STRANGER WHO CAN STEP UP AND DONATE THEIR HEALTHY BLOOD STEM CELLS TO GIVE THEM THE CHANCE AT A LIFE-SAVING TRANSPLANT. |
| Form 990, Part III, Line 4d Description of other program services | (Expenses $ 22,381,318 including grants of $ 2,269,711)(Revenue $ 70,427) PUBLIC AWARENESS: NMDP PARTNERS WITH NMDP FOUNDATION TO ADVANCE VARIOUS INITIATIVES TIED TO THE SHARED MISSION. THESE PROGRAMS INCLUDE: NMDP PROVIDES COMPREHENSIVE EDUCATION AND SUPPORT SERVICES TO PATIENTS AND THEIR FAMILIES THROUGH ONE-ON-ONE NAVIGATION SUPPORT, VIDEO, PRINTED, AND DIGITAL EDUCATION RESOURCES, COUNSELING, NMDP PEER CONNECT PROGRAM, NMDP SURVIVORSHIP PROGRAM, NMDP SICKLE CELL WARRIOR PROGRAM, AND THE JASON CARTER CLINICAL TRIALS SEARCH AND SUPPORT PROGRAM, WHICH HELPS PATIENTS WITH LIFE-THREATENING BLOOD DISORDERS FIND CLINICAL TRIALS. NMDP Foundation RAISES FUNDS TO SUPPORT THESE CRITICAL SERVICES. |
| Form 990, Part VI, Line 2 FAMILY/BUSINESS RELATIONSHIPS AMONGST INTERESTED PERSONS | The following Directors of the NMDP have a reportable business relationship: Anne McGeorge and Amy Ronneberg (Ms. McGeorge and Ms. Ronneberg were both voting directors of Magenta Therapeutics during FY2023). The following Directors of NMDP have a reportable business relationship: Anne McGeorge and Amy Ronneberg (Ms. McGeorge and Ms. Ronneberg were both voting directors of CLEAR Insurance, Ltd. during FY2023). |
| Form 990, Part VI, Line 1a Delegate broad authority to a committee | The NMDP Bylaws state: "The Executive Committee shall at all times include the Chair of the Board, the Immediate Past Chair (when in office), the Chair-Elect (when in office), the Secretary, the Chief Executive Officer, and any Government Representatives. Any and all additional members of the Executive Committee shall be Voting Directors, except the Chief Executive Officer and Government Representatives, who shall serve as non-voting ex officio members of the committee. The Executive Committee shall, to the extent allowed by applicable law, have the authority of the Board in the oversight of the business of the Corporation between meetings of the full Board and shall have such other authority and responsibilities as set forth in the Executive Committee Charter." The Executive Committee Charter states: "The Executive Committee shall, to the extent determined by the Board of Directors, have the authority of the Board in the oversight of the business of the Corporation between meetings of the full Board. The Executive Committee shall manage the business of the Corporation and direct and coordinate the work activities of committees between meetings of the Board. The Executive Committee shall also review key Board-level policies and procedures on a periodic basis and recommend new or modified policies and initiatives. With the Board, the Executive Committee is responsible for oversight of the strategic planning process, developing a calendar for Board activities, and providing guidance to the Board and Corporation staff regarding the appropriate roles of each. The Executive Committee, in close coordination with the Audit & Finance Committee, shall monitor the financial integrity of operations, including evaluating performance against the Corporation's budget and strategic and business plans. In addition, the Executive Committee shall represent the Corporation in its interactions with other organizations, Congress, federal agencies, participating centers, constituent groups, professional organizations, and the public." |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | Form 990 review process: The organization contracted with the outside public accounting firm, Baker Tilly, to prepare the Form 990. Preparing the details and supporting reports for the return is a collaborative effort among a small group of individuals in the financial reporting & compliance area of finance, internal audit and human resources. Once a draft is received back from Baker Tilly, it is reviewed by the team that pulled the details together, Director, Finance and Corporate Controller, and NMDP Chief Financial Officer. The NMDP CHIEF ADMINISTRATIVE OFFICER also reviews the governance sections. A copy of the return is provided to the organization's audit and finance committee and board of directors prior to filing. |
| Form 990, Part VI, Line 12c Conflict of interest policy | The Conflict of Interest Policy states the following: "The existence of an actual or potential conflict of interest turns on the specific facts and circumstances in each case. If a Member has an interest which may conflict with those of the Organizations, he or she must immediately disclose the matters and discuss them fully and frankly with the applicable Organization's full Board or its Executive Committee, as set forth in detail below. A Member must not participate in any matter in which that Member may have an actual or potential conflict of interest without the express approval of the applicable Organization's Board of Directors or Executive Committee of the Board of Directors (Executive Committee). All Members must disclose to the applicable Organization's Board of Directors or Executive Committee all conflicts of interest and reportable relationships, and must annually complete and submit the Conflict of Interest Questionnaire which is required by this Policy. Whenever in the course of events a Member's circumstances change such that the Member knows or has reason to believe that the Member may have an actual or perceived conflict of interest, such Member shall promptly disclose the potential conflict to the applicable Organization's Board of Directors or Executive Committee. For the purposes of this Article, a Member may formally disclose a conflict or reportable relationship to the NMDP Chief Executive Officer (CEO), the Chief Advancement Officer, or the NMDP Chief Administrative Officer and General Counsel (CAO), as applicable, who shall inform the applicable Organization's Board of Directors or Executive Committee for resolution. As noted herein, if the potential conflict involves a Director or Committee Member, that Director or Committee Member shall not participate in or vote upon such matters until the question of the existence of the conflict of interest has been resolved in accordance with this Policy. Likewise, an officer or key employee may not become substantially involved in decision-making involving any covered litigation, contract or transaction until the resolution of the matter in accordance with this Policy." |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | The NMDP Bylaws state: "The Compensation Committee shall be comprised only of Voting Directors and shall include the Chair of the Board and at least one (1) non-officer Board member as voting committee members. The Compensation Committee shall review and evaluate the overall compensation and benefit structure of the Corporation and shall have such other authority and responsibilities as set forth in the Compensation Committee Charter." The Compensation Committee Charter states: "The Committee shall review and evaluate the overall compensation and benefit structure of the Corporation, and approve and adopt a compensation philosophy and principles consistent with the Corporation's non-for-profit status (the "Compensation Philosophy and Principles"). The Committee shall conduct the Chief Executive Officer ("CEO") performance evaluation. The Committee shall make CEO total compensation and benefit recommendations to the Executive Committee, consistent with the Compensation Philosophy and Principles. In making compensation and benefit recommendations for the CEO, the Committee shall utilize, among other things, comparability data for compliance with IRS Intermediate Sanction provisions so as to allow the Corporation to take advantage of the rebuttable presumption of reasonableness. On a periodic basis, the Committee shall obtain comparability data from an independent compensation consultant. In addition, the Committee shall advise the CEO in his/her evaluation of and decisions regarding the compensation of and benefits for senior Corporation employees, as well as the President (or equivalent leader) of any subsidiary of the Corporation reporting to the CEO (together, "Senior Leadership"). In advising the CEO in making his/her compensation and benefit decisions for Senior Leadership, the Committee shall ensure that such decisions are consistent with the Compensation Philosophy and Principles, and utilize, among other things, comparability data for compliance with IRS Intermediate Sanction provisions. If decisions proposed by the CEO are outside the parameters of the Compensation Philosophy and Principles, the CEO must obtain the Committee's approval prior to implementation." |
| Form 990, Part VI, Line 19 Required documents available to the public | How documents are made available to the public: The conflict of interest policy, articles of incorporation and consolidated audited financial statements are available to the public upon request. Summary financial statements are also included in our annual report, which is mailed to key stakeholders and posted on our website. Additionally, articles of incorporation are available through the MN office of the secretary of state, and consolidated audited financial statements may be obtained at the MN office of the attorney general. |
| Form 990, Part XII, Line 2c | THE ORGANIZATION HAS NEITHER CHANGED ITS OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR. |
| form 990, page 1, item B: | THE RETURN FOR THE CURRENT YEAR IS BEING AMENDED TO REFLECT THE FOLLOWING: 1. FORM 990, PART VII, SECTION A, LINES 1A, 1B, AND 1D COLUMN (F) ARE REVISED TO REFLECT THE ACCURATE COMPENSATION REPORTING FOR THE FISCAL YEAR. AFTER FILING FORM 990, IT WAS DISCOVERED THE ORGANIZATION ERRONEOUSLY FAILED TO INCLUDE IN COLUMN (F) THE AMOUNT EARNED BY ELIGIBLE INDIVIDUALS UNDER THE ORGANIZATION'S LONG-TERM INCENTIVE PLAN. 2. AFTER FILING FORM 990, IT WAS DISCOVERED THE COMPENSATION FOR M. MCCULLOUGH AND J. SMOLICH WERE INADVERTENTLY SWITCH. THIS AMENDMENT CORRECTS THE COMPENSATION REPORTING FOR EACH EMPLOYEE. 3. SCHEDULE J PART II, COLUMN (C), COLUMN (E), AND COLUMN (F) ARE REVISED TO REFLECT THE ACCURATE REPORTING OF COMPENSATION AND DEFERRED COMPENSATION FOR THE PERIOD. AMOUNTS DEFERRED AND PAID UNDER THE ORGANIZATION'S LONG-TERM INCENTIVE PLAN WERE ERRONEOUSLY EXCLUDED FROM THE FILING. THIS AMENDMENT CORRECTS THE INADVERTENT ERROR. SEE SCHEDULE J PART III LINE 7 FOR ADDITIONAL DISCLOSURES. |
| Software ID: | 22016089 |
| Software Version: | 2022v5.0 |
|
Affiliated Group Business Name:
NATIONAL MARROW DONOR PROGRAM
Address. Either US or Foreign Type:
500 N 5TH ST
MINNEAPOLIS, MN554011206 EIN:
84-0865803
Electing Organization Checkbox:
Total Grassroots Lobbying:
194,368
Total Direct Lobbying:
898,244
Total Lobbying Expenditures:
1,092,612
Other Exempt Purpose Expenditures:
569,713,452
Total Exempt Purpose Expenditures:
570,806,064
Lobbying Nontaxable Amount:
1,000,000
Grassroots Nontaxable Amount:
250,000
Tot Lobbying Grassroot Minus Non Tx:
0
Tot Lobby Expend Mns Lobbying Non Tx:
92,612
Share Of Excess Lobbying:
|
|
Affiliated Group Business Name:
NMDP Foundation
Address. Either US or Foreign Type:
500 N 5TH ST
Minneapolis, MN55401 EIN:
41-1704734
Electing Organization Checkbox:
Total Grassroots Lobbying:
0
Total Direct Lobbying:
0
Total Lobbying Expenditures:
0
Other Exempt Purpose Expenditures:
18,261,426
Total Exempt Purpose Expenditures:
18,261,426
Lobbying Nontaxable Amount:
1,000,000
Grassroots Nontaxable Amount:
250,000
Tot Lobbying Grassroot Minus Non Tx:
0
Tot Lobby Expend Mns Lobbying Non Tx:
0
Share Of Excess Lobbying:
|